SPRR1A and amyotrophic lateral sclerosis: Sprr1a was also found upregulated across vulnerable MNs, concordant with a response to axon damage in ALS (Fig. 4C–E), and RNAscope on spinal cord sections confirmed the upregulation with disease at the symptom-onset stage (P ≤ 0.0001) (Fig. 4H).